Showing 6931-6940 of 8826 results for "".
- Acne-Specific Dermatology Platform Site Goes Livehttps://practicaldermatology.com/news/20130801-acne-specific_dermatology_platform_site_goes_live/2459485/
- Merz Acquires Neocutis' Skin Care Divisionhttps://practicaldermatology.com/news/20130801-merz_acquires_neocutis/2459486/Merz Pharma Group has acquired the cosmetics, over-the-counter, and prescription skin care businesses of Swiss dermatology company Neocutis. The company's North American division will integrate marketing of Neocutis' line of physician-dispensed topical skin care products in the US. “Neocutis' line
- Valeant Unveils Advanced Deep Cleansing Duo for Acnehttps://practicaldermatology.com/news/20130730-valeant_unveils_advanced_deep_cleansing_duo_for_acne/2459487/Valeant Pharmaceuticals is has added additional products to its new AcneFree product line. Rounding out AcneFree's daily cleansing option are the AcneFree Advanced Cleansing Brush and AcneFree Oil-Free Purifying Cleanser. The Cleansing Brush features a two-speed rotating brush head to exfoliate and
- iovera Treatment Approved in Canadahttps://practicaldermatology.com/news/20130725-iovera_treatment_approved_in_canada/2459492/ioveradegrees received regulatory approval in Canada. Developed by myoscience, inc. in California, the ioveradegrees system targets forehead wrinkles using Focused Cold TherapyTM, a technology that helps to temporarily reduce the appearance of wrinkles without leaving any toxins or chemicals behind
- Pierre Fabre, Founder of Namesake Pharmaceutical Company, Dieshttps://practicaldermatology.com/news/20130725-pierre_fabre_founder_of_namesake_pharmaceutical_company_dies/2459493/Pierre Fabre, President and Founder of Pierre Laboratories has died. He founded the company and 1961 and has since helped it grow into the third-largest French pharmaceutical company.
- European Commission Grants Conditional Approval to Erivedgehttps://practicaldermatology.com/news/20130716-european_commission_grants_conditional_approval_to_erivedge/2459497/The European Commission has granted conditional approval to Erivedge (vismodegib) for the treatment of adult patients with symptomatic metastatic basal cell carcinoma (BCC) or locally advanced BCC inappropriate for surgery or radiotherapy. The Commission granted the conditional approval based upon t
- Geneticists Research Cleft Palate and Skin Deformitieshttps://practicaldermatology.com/news/20130614-geneticists_research_cleft_palate_and_skin_deformities/2459514/Scientists at Cold Spring Harbor Laboratory (CSHL) solved the mystery of why some infants are born with cleft palate and major deformities of the skin and limbs, while other infants with the same genetic mutation bear little or no sign of the illness, called Ectodactyly, Ectodermal dysplasia, Clefti
- Suneva Selects Quinnova to Co-promote ReFissahttps://practicaldermatology.com/news/20130610-suneva_selects_quinnova_to_co-promote_refissa/2459520/Suneva Medical, Inc. selected Quinnova Pharmaceuticals, LLC to co-promote ReFissa. ReFissa is the only FDA approved 0.05% tretinoin emollient cream indicated for the treatment of fine wrinkles, mottled hyperpigmentation, and tactile roughness of facial skin.
- Jurlique Product Supports the Underservedhttps://practicaldermatology.com/news/20130607-jurlique_product_supports_the_underserved/2459521/The Jurlique Ideas of Beauty Fund by Jurlique and Chrysalis supports the empowerment of women to lead better lives. Through the fund, Jurlique donates to organizations around the world committed to helping women. Proceeds from every
- Renaissance and GlaxoSmithKline Transfer Nine Productshttps://practicaldermatology.com/news/20130605-renaissance_and_glaxosmithkline_transfer_nine_products/2459522/Renaissance Acquisition Holdings, LLC and GlaxoSmithKline entered into an agreement giving Renaissance the rights in the USA to manufacture, market, and sell six dermatology and three anti-viral products from GSK. The products from GSK and Stiefel, which will be marketed through Renaissance's bran